Paper39367476
Production of α-ketoisovalerate with whey powder by systemic metabolic engineering of Klebsiella oxytoca.
Sun W and 14 others. Microb Cell Fact, 2024. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Production of α-ketoisovalerate with whey powder by systemic metabolic engineering of Klebsiella oxytoca. Papers, record 39367476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39367476
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Production of α-ketoisovalerate with whey powder by systemic metabolic engineering of Klebsiella oxytoca.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Klebsiella oxytoca | Major topic |
| Whey | Major topic |
| Metabolic Engineering | Major topic |
| Hemiterpenes | Major topic |
| Fermentation | Major topic |
| Powders | |
| Acetolactate Synthase | |
| Keto Acids |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 32300045 | National Natural Science Foundation of China | PubMed | PubMed | ||
| 2022YFC2106000 | the National Key R&D Program of China | PubMed | PubMed | ||
| ZR2022QC092 | Youth Program of Natural Science Foundation of Shandong Province | PubMed | PubMed | ||
| 2023M742085 | China Postdoctoral Science Foundation | PubMed | PubMed | ||
| 23-2-1-31-zyyd-jch | Youth Program of Natural Science Foundation of Qingdao City | PubMed | PubMed | ||
| No. SDCX-ZG-202400150 | Postdoctoral Innovation Program of Shandong Province | PubMed | PubMed | ||
| QDBSH20230201011 | Qingdao Postdoctoral Research Project | QDBSH202302 | PubMed | NIH RePORTER | |
| M2023-02 | State Key Laboratory of Microbial Technology Open Projects Fund | PubMed | PubMed | ||
| SKLMTFCP-2023-03 | State Key Laboratory of Microbial Technology | PubMed | PubMed |
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38554761 | Metabolically engineer Clostridium saccharoperbutylacetonicum for comprehensive conversion of acid whey into valuable biofuels and biochemicals. | Bioresour Technol | 2024 | https://conductscience.org/library/papers/38554761 | PubMed |
| 2 | 37152640 | System metabolic engineering of Escherichia coli W for the production of 2-ketoisovalerate using unconventional feedstock. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37152640 | PubMed |
| 3 | 22721610 | Cheese whey management: a review. | J Environ Manage | 2012 | https://conductscience.org/library/papers/22721610 | PubMed |
| 4 | 3085653 | Resolution of branched-chain oxo acid dehydrogenase complex of Pseudomonas aeruginosa PAO. | Biochem J | 1986 | https://conductscience.org/library/papers/3085653 | PubMed |
| 5 | 21744508 | A synthetic metabolic pathway for production of the platform chemical isobutyric acid. | ChemSusChem | 2011 | https://conductscience.org/library/papers/21744508 | PubMed |
| 6 | 38295958 | Efficient L-valine production using systematically metabolic engineered Klebsiella oxytoca. | Bioresour Technol | 2024 | https://conductscience.org/library/papers/38295958 | PubMed |
| 7 | 23432904 | Genome-scale reconstruction and in silico analysis of Klebsiella oxytoca for 2,3-butanediol production. | Microb Cell Fact | 2013 | https://conductscience.org/library/papers/23432904 | PubMed |
| 8 | 38417463 | Microbial production of branched chain amino acids: Advances and perspectives. | Bioresour Technol | 2024 | https://conductscience.org/library/papers/38417463 | PubMed |
| 9 | 31562926 | Engineering Yarrowia lipolytica for the utilization of acid whey. | Metab Eng | 2020 | https://conductscience.org/library/papers/31562926 | PubMed |
| 10 | 33068182 | Metabolic engineering of Escherichia coli W for isobutanol production on chemically defined medium and cheese whey as alternative raw material. | J Ind Microbiol Biotechnol | 2020 | https://conductscience.org/library/papers/33068182 | PubMed |
| 11 | 38347493 | Efficient production of 1,2,4-butanetriol from corn cob hydrolysate by metabolically engineered Escherichia coli. | Microb Cell Fact | 2024 | https://conductscience.org/library/papers/38347493 | PubMed |
| 12 | 31063878 | Dynamic gene expression engineering as a tool in pathway engineering. | Curr Opin Biotechnol | 2019 | https://conductscience.org/library/papers/31063878 | PubMed |
| 13 | 37154424 | Metabolic Engineering of Saccharomyces cerevisiae for Vitamin B5 Production. | J Agric Food Chem | 2023 | https://conductscience.org/library/papers/37154424 | PubMed |
| 14 | 33764372 | A modified pCas/pTargetF system for CRISPR-Cas9-assisted genome editing in Escherichia coli. | Acta Biochim Biophys Sin (Shanghai) | 2021 | https://conductscience.org/library/papers/33764372 | PubMed |
| 15 | 18689519 | Insertional inactivation of branched-chain alpha-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. | Appl Environ Microbiol | 2008 | https://conductscience.org/library/papers/18689519 | PubMed |
| 16 | 20935122 | Metabolic engineering of Corynebacterium glutamicum for 2-ketoisovalerate production. | Appl Environ Microbiol | 2010 | https://conductscience.org/library/papers/20935122 | PubMed |
| 17 | 33300786 | Pyruvate Production from Whey Powder by Metabolic Engineered Klebsiella oxytoca. | J Agric Food Chem | 2020 | https://conductscience.org/library/papers/33300786 | PubMed |
| 18 | 33009939 | Combining metabolic engineering and evolutionary adaptation in Klebsiella oxytoca KMS004 to significantly improve optically pure D-(-)-lactic acid yield and specific productivity in low nutrient medium. | Appl Microbiol Biotechnol | 2020 | https://conductscience.org/library/papers/33009939 | PubMed |
| 19 | 38006983 | An efficient production of bio-succinate in a novel metabolically engineered Klebsiella oxytoca by rational metabolic engineering and evolutionary adaptation. | Bioresour Technol | 2024 | https://conductscience.org/library/papers/38006983 | PubMed |
| 20 | 33548455 | Comparative analysis of the chemical and biochemical synthesis of keto acids. | Biotechnol Adv | 2021 | https://conductscience.org/library/papers/33548455 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41704463 | Multistep metabolic engineered Klebsiella oxytoca for efficient l-leucine production. | Synth Syst Biotechnol | 2026 | https://conductscience.org/library/papers/41704463 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39367476
GET https://conductscience.org/api/papers/v1/39367476/references?page=2